Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Neuronetics Inc (STIM)

Neuronetics Inc (STIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Neuronetics Inc 3222 PHOENIXVILLE PIKE MALVERN PA 19355 USA

www.neurostar.com P: 610-640-4202 F: 610-640-4206

Description:

Neuronetics, Inc. is a commercial-stage medical device company. It focused on designing, developing, and marketing products for patients who suffer from psychiatric disorders. NeuroStar Advanced Therapy System(R), is the transcranial magnetic stimulation treatment for depressive disorder. Neuronetics, Inc. is based in Malvern, United States.

Key Statistics

Overview:

Market Capitalization, $K 112,406
Enterprise Value, $K 112,006
Shares Outstanding, K 29,975
Annual Sales, $ 71,350 K
Annual Net Income, $ -30,190 K
Last Quarter Sales, $ 20,310 K
Last Quarter Net Income, $ -5,380 K
EBIT, $ -30,560 K
EBITDA, $ -28,550 K
60-Month Beta 2.44
% of Insider Shareholders 9.80%
% of Institutional Shareholders 53.59%
Float, K 27,037
% Float 90.20%
Short Volume Ratio 0.32

Growth:

1-Year Return 57.85%
3-Year Return -66.48%
5-Year Return -78.71%
5-Year Revenue Growth 35.18%
5-Year Earnings Growth 60.97%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.19 on 03/05/24
Latest Earnings Date 05/07/24
Earnings Per Share ttm -1.07
EPS Growth vs. Prev Qtr 42.42%
EPS Growth vs. Prev Year 36.67%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

STIM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -72.77%
Return-on-Assets % -29.25%
Profit Margin % -42.31%
Debt/Equity 1.73
Price/Sales 1.62
Price/Cash Flow N/A
Price/Book 3.16
Book Value/Share 1.18
Interest Coverage -4.57
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar